Deutsche Bank pounds the table for Allscripts (MDRX) following meetings with management, touting the company's "attractive valuation and solid growth momentum." The firm also claims Allscripts is already generating over $200M in cross-selling synergies from its acquisition of Eclipsys.
Alscripts is leading the charge of signing up hospitals and doctor's groups to a nationwide healthcare and prescription network, where doctors can access patient's records more easily.
Here is the long term chart going back to 2004:
Tuesday, September 27, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment